Developer of a life-saving digital health device designed to prevent Sudden Cardiac Death (SCD). The company's device uses a patch-based Wearable Cardioverter Defibrillator (WCD) that monitors a patient's heart, enabling patients to keep a track of their heart and stay healthy.
Generating Revenue
Privately Held (backing)
Venture Capital-Backed
The company raised $1.5 million of convertible debt financing from undisclosed investors on September 20, 2018. Earlier, the company raised $25 million of Series B venture funding from undisclosed investors on August 19, 2016, putting the company's pre-money valuation at $225 million.
Add a review